Common Contracts

THE SYMBOL “[****]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED AMENDMENT NO. 1 TO AGREEMENT

Agreement • May 15th, 2019 • RedHill Biopharma Ltd. • Pharmaceutical preparations

• Contract Type
  Agreement
• Filed
  May 15th, 2019
• Company
  RedHill Biopharma Ltd.
• Industry
  Pharmaceutical preparations

This Amendment No.1 to Agreement is made as of February 26, 2018 (the “Amendment Effective Date”) by and between RedHill Biopharma Ltd. (“RedHill”) and Salix Pharmaceuticals, Inc. (“Salix”).

AMENDMENT NO. 1 TO AGREEMENT

Agreement • February 26th, 2019 • RedHill Biopharma Ltd. • Pharmaceutical preparations

• Contract Type
  Agreement
• Filed
  February 26th, 2019
• Company
  RedHill Biopharma Ltd.
• Industry
  Pharmaceutical preparations

This Amendment No.1 to Agreement is made as of February 26, 2018 (the “Amendment Effective Date”) by and between RedHill Biopharma Ltd. (“RedHill”) and Salix Pharmaceuticals, Inc. (“Salix”).